Washington University launches Alzheimer's trial

Thursday, September 19, 2013 | 7:34 a.m. CDT; updated 1:11 p.m. CDT, Thursday, September 19, 2013

ST. LOUIS — Researchers at Washington University in St. Louis are launching a clinical trial to see if new drug treatments given before dementia can prevent Alzheimer's disease.

The trial will test two new drug treatments. It is led by Randall Bateman, a neurology professor at the Washington University School of Medicine.

Funding is a mix of private and public money, including a $1.5 million grant from the National Institutes of Health and a $4.2 million grant from the Alzheimer's Association.

University officials say research in recent years has indicated that prevention is more likely to succeed than treatment after cognitive impairment.

Like what you see here? Become a member.

Show Me the Errors (What's this?)

Report corrections or additions here. Leave comments below here.

You must be logged in to participate in the Show Me the Errors contest.


Leave a comment

Speak up and join the conversation! Make sure to follow the guidelines outlined below and register with our site. You must be logged in to comment. (Our full comment policy is here.)

  • Don't use obscene, profane or vulgar language.
  • Don't use language that makes personal attacks on fellow commenters or discriminates based on race, religion, gender or ethnicity.
  • Use your real first and last name when registering on the website. It will be published with every comment. (Read why we ask for that here.)
  • Don’t solicit or promote businesses.

We are not able to monitor every comment that comes through. If you see something objectionable, please click the "Report comment" link.

You must be logged in to comment.

Forget your password?

Don't have an account? Register here.